Reporting on circulating tumor DNA monitoring in metastatic cancer-From clinical validity to clinical utility

Caroline Brenner Thomsen*, Amanda Dandanell Juul, Anna Cecilie Lefèvre, Christina Glismand Truelsen, Edina Dizdarevic, Heidi Ryssel, Ina Mathilde Kjaer, Karen Lycke Wind, Louise Bach Callesen, Louise Faaborg Larsen, Malene Støchkel Frank, Rikke Fredslund Andersen, Karen-Lise Garm Spindler, Anders Jakobsen

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftKommentar/debatForskning

Abstract

This commentary attempts to discuss the required standardization of circulating tumor DNA (ctDNA) analyses and thereby improve the clinical validity of ctDNA monitoring in the metastatic setting of solid tumors.

OriginalsprogEngelsk
Sider (fra-til)2052-2057
Antal sider6
TidsskriftCancer
Vol/bind128
Udgave nummer11
Tidlig onlinedato18 mar. 2022
DOI
StatusUdgivet - 1 jun. 2022

Fingeraftryk

Udforsk hvilke forskningsemner 'Reporting on circulating tumor DNA monitoring in metastatic cancer-From clinical validity to clinical utility' indeholder.

Citationsformater